From exploring the role that science and technology play in early health in 2005 and 2006, to pandemic influenza in 2007, nutrition in 2008, and multidrug-resistant tuberculosis (MDR-TB) in 2009, each year, the Pacific Health Summit has sought to tackle a critical global health issue. In 2010, our maternal and newborn health theme created unique opportunities for private sector engagement with the broader global health community, and in 2011, the Summit addressed the theme of vaccines. The 2012 Summit focused on the theme of affordability and technologies for health. Future Summit activities will continue to build on all of these conversations, exploring progress made, challenges that remain, new twists and discoveries, and opportunities for creative partnerships that still abound.
2012 Summit | Game Changers: Affordability and Technologies for Health
The 2012 Pacific Health Summit provided the opportunity for the world’s top experts from all sectors to discuss how a spectrum of technologies are, can, and will be game changers for global health. This was, and continues to be, a critical conversation, as both developing and developed societies grapple with the need to put affordability, access, and equity at the top of their health agendas, while facing an increasingly complex disease burden that is heedless of borders.
- Balancing Value, Accessibility, and Price: In assessing affordability, rather than focusing exclusively on price, Summit participants were challenged to take a broader look at the life-cycle value, accessibility, and appropriateness of a wide range of technologies. Such technologies included devices, diagnostics, drugs, vaccines, ICT and mHealth, as well as operational and delivery processes, particularly for low-resource settings.
- Emerging Sources of Innovation: Innovation and rapidly evolving technologies are emerging from a diverse set of geographies. Summit discussions explored how this diversity can serve as a powerful and often “disruptive” force in driving access to affordable technologies.
- Learning from Our Misadventures: By sharing experiences—failures and successes—policymakers, donors, and industry leaders discussed how to effectively prioritize investment and implementation decisions in a field where new and improved technologies and processes are rapidly emerging.
- Whose Game Are We Changing? Are we effectively targeting the end-users and to what extent does cultural context impact technology use? Collectively, global health leaders discussed the role of technology in addressing the shifting landscape of health and examined how today’s innovations are shaping health and development for the future.
2011 Summit | Vaccines: Harnessing Opportunity in the 21st Century
The 2011 Summit addressed vaccines in a global context, with emphasis on middle- and low-income countries facing disproportionately significant funding, delivery, and access challenges. The theme evolved beside a vaccines manufacturing landscape that is increasingly more global. Plenary sessions honed in on how the vaccines paradigm might be affected by new international players in terms of innovation, pricing, and collaboration. A smaller workshop targeted the direct role that China has to play now and in the near future. Cold-chain logistics, funding issues, and how to address trust, cultural, and behavioral barriers that feed suspicion of immunization efforts were other critical points of debate.
For a detailed look at the proceedings, please view the 2011 Summit report.
2010 Summit | Maternal and Newborn Health: The Crux of a Decent Humanity
Debuting at its now bi-annual London location, the 2010 Summit convened around the theme of “Maternal and Newborn Health:
The Crux of a Decent Humanity.” Recognizing that every year, nearly 350,000 women die during pregnancy or childbirth,
and 3.6 million children die in their first four weeks of life, leaders tackled issues like integrating new technologies
in the MNH field, including utilizing information and communicative technologies to link expectant mothers with relevant
health messages. The Summit also built on its annual mission to effectively utilize the business sector’s unique capability
to drive advancement in health, drawing awareness to opportunities that exist in adapting and bringing medical advancements to rural areas. Sessions on financing mechanisms and the smooth incorporation of MNH budgets into the overall global health
agenda were other foci of conversation.
For a detailed look at the proceedings, please view the 2010 Summit report.
2009 Summit | Multidrug-Resistant Tuberculosis: Overcoming Global Resistance
The critical problem of how to address Multidrug-Resistant Tuberculosis’ (MDR-TB) pernicious spread was addressed through the 2009 Summit theme: "MDR-TB: Overcoming Global Resistance.” Over the course of two days, participants explored ways to strengthen existing approaches to basic TB control and MDR-TB management. The assembled quorum critically assessed the need to push staid TB technologies and treatments into the 21st century, noting the unexplored benefits that accelerated uptake of therapies like fixed-dose combination may provide. With high rates of discontinued medical treatment fueling MDR-TB prevalence, Summit participants discussed alternative delivery and oversight plans. Another top priority, eliminating the dearth of general awareness and funding compared to other diseases like HIV/AIDS and malaria, was prevalent throughout the Summit.
For a detailed look at the proceedings, please view the 2009 Summit report.
2008 Summit | The Global Nutrition Challenge: Getting a Healthy Start
"The Global Nutrition Challenge" headlined as the 2008 theme, focusing on the complex challenge of too little of the right
nutrition for vulnerable populations and the rapidly emerging health threat of too much of the wrong nutrition in both
developed and developing societies. The role of public-private partnerships emerged as an essential focus in the effort to
ensure access to requisite sources of nutrition. Initiative for action was catalyzed through talk of how to utilize private
industry’s unparalleled ability to reach vast populations, especially through food fortification and existing supply chains.
Another key area of discussion was the critical challenge of ensuring a "healthy start" for children by stressing maternal
and infant nutrition.
For a detailed look at the proceedings, please view the 2008 Summit report.
2007 Summit | Pandemics: Working Together for an Effective and Equitable Response
In 2007, the Summit addressed the topic of pandemic preparedness and prevention. This interest dates
back to the inaugural Summit in June 2005, when Jong-wook Lee, the then Director-General of the World
Health Organization, eloquently and passionately addressed the need for greater attention on the threat
of a global avian influenza pandemic. Issues, including the preparedness of manufacturers, the strength
of existing infrastructure, supply chain management, and the repercussions of panic during a pandemic were at
the epicenter of Summit discussions. Special emphasis was placed on the issue of developing and stockpiling
pre-pandemic H5N1 vaccines.
For a detailed look at the proceedings, please view the 2007 Summit report.
2006 Summit | Connecting Science, Innovation, and Policy for a Healthier World
In 2006, the Summit continued its focus on emerging science and technology and its intersection with health policy,
particularly in the area of "early health" and the value of early detection and intervention. Plenary sessions focused
on cost-associative benefits of prevention based health care, the antaean, pre-emptive value of vaccines, and the role
that mobile technology, health information collection and sharing across networks, and other innovations have to play in
streamlining care and reducing pecuniary burdens. Against the backdrop of the recent SARS and avian flu concerns, participants
also met on the pressing question of how to prepare for the next pandemic.
For a detailed look at the proceedings, please view the 2006 Summit report.
2005 Summit | Building Partnerships to Create a Healthier Future
The inaugural Summit, held in 2005 addressed four conceptual building blocks for early health: the assessment of health risk,
the prevention of disease, early detection of disease, and early treatment of disease. Participants delved into discussions
centering on integral health issues underlying these concepts, including the question of what constitutes an ideal healthcare model
and the inherent potential of genomic research and new technologies. Conceived as a forum in which to gather health leaders from East
and West together, and convened with representatives from 20 countries, Summit attendees followed through on the meeting’s
international precedent with an “East Meets West: Personal Health” panel discussion.
For a detailed look at the proceedings, please view the 2005 Summit report.